Currently, the share price for Remus Pharmaceuticals Ltd. is delayed. Login to view live prices.
Remus Pharmaceuticals Ltd.
₹2,590.00
NSE
-- ( -- %) 1D
- Prev. Close2,590.00
- Upper Circuit3,080.50
- Lower Circuit2,053.70
Analyst Sentiment For Remus Pharmaceuticals Ltd.
There seem to be no recommendations on this stock from the analyst universe covered
Returns
Remus Pharmaceuticals Ltd.'s Info & Management
Remus Pharmaceuticals is engaged in the business of Marketing and distribution of API and Finished Formulations of Pharmaceutical drugs, trading of API (Active Pharmaceutical Ingredient) and Provision for Technical consultancy services in various countries including India.
- Company Secretary,Compliance OfficerDeval Patel
- Chief Financial OfficerMs. Anjali Shah
FAQs on Remus Pharmaceuticals Ltd.
What is the share price of Remus Pharmaceuticals Ltd.?
Remus Pharmaceuticals Ltd. share price is ₹2,585.00 as of September 6, 2024, 03:28 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Remus Pharmaceuticals Ltd.?
The 52-week high and low of Remus Pharmaceuticals Ltd. is ₹2,834.75 and ₹1,012.50 respectively as of September 6, 2024, 03:28 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What is the PB ratio of Remus Pharmaceuticals Ltd.?
The trailing twelve month (TTM) PB ratio of Remus Pharmaceuticals Ltd. is 17.41 as of September 8, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.
What are the Upper Circuit and Lower Circuit of Remus Pharmaceuticals Ltd.?
The Upper Circuit of Remus Pharmaceuticals Ltd. is ₹3,081.
The Lower Circuit of Remus Pharmaceuticals Ltd. is ₹2,054.
What is the ROE of Remus Pharmaceuticals Ltd.?
Remus Pharmaceuticals Ltd. reported an ROE of 47.91% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Remus Pharmaceuticals Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Remus Pharmaceuticals Ltd., Promoter held 70.7%, the FII held 3%, DII held 0.7% and the public held 25.9% of the total shares.
How to buy Remus Pharmaceuticals Ltd. Share?
You can easily buy shares of Remus Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Remus Pharmaceuticals Ltd.?
The fair value of Remus Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer